The most important financial indicators for the company International Stem Cells Reserve Srl - Unique Identification Number 30759020:
sales in 2023 was
15.071
euro, registering a net profit of
-7.162
euro and having an average number of
employees.
Firma isi desfasoara activitatea in domeniul Inchirierea si subinchirierea bunurilor imobiliare proprii having the NACE code 6820.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -41.7%, from 25.915 euro in the year 2022, to 15.071 euro in 2023.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
International Stem Cells Reserve Srl - CUI 30759020
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
367.692
354.073
333.945
330.757
308.747
287.137
263.732
244.257
230.103
214.539
Current Assets
124.538
128.882
124.416
38.564
42.205
35.178
32.054
26.573
25.309
13.435
Inventories
82.705
85.647
84.774
0
0
0
0
0
0
0
Receivables
28.830
36.808
30.851
31.675
36.343
33.614
26.862
5.233
20.999
9.578
Cash
13.003
6.427
8.791
6.889
5.863
1.564
5.192
21.340
4.310
3.857
Shareholders Funds
-32.242
-56.683
-75.631
-154.145
-166.680
-185.612
-199.686
-209.603
-247.559
-253.970
Social Capital
11.155
11.249
11.134
10.945
10.745
10.537
10.337
10.108
10.139
10.108
Debts
527.612
542.804
537.124
526.546
520.656
510.892
498.381
483.277
505.824
484.788
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"6820 - 6820"
CAEN Financial Year
6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
13.435 euro in 2023 which includes Inventories of
0 euro, Receivables of
9.578 euro and cash availability of
3.857 euro.
The company's Equity was valued at
-253.970 euro, while total Liabilities amounted to
484.788 euro.
Equity decreased by -7.162 euro, from -247.559 euro in 2022, to -253.970 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - International Stem Cells Reserve Srl